Novel Pathology Classification System (FEMASK-Score) for Charcot Neuropathic Arthropathy Reveals Intraneural Vasculopathy and Predicts Outcome

Category: Basic Sciences/Biologics; Ankle; Diabetes; Midfoot/Forefoot Introduction/Purpose: Charcot neuropathic arthropathy (CNA) is a debilitating, rapidly destructive degenerative joint disease that occurs in diabetic, neuropathic midfoot. Clinicoradiologic assessment for CNA previously relied on...

Full description

Bibliographic Details
Main Authors: Jesse King BSc, Ben Murie, Julie C. Fanburg-Smith, Chris M. Stauch, Donald Flemming MD, Michael J. Klein, Elizabeth E. Frauenhoffer, Madelaine W. Fritsche BSc, Jessica Smith, John Elfar, Michael C. Aynardi MD
Format: Article
Language:English
Published: SAGE Publishing 2020-10-01
Series:Foot & Ankle Orthopaedics
Online Access:https://doi.org/10.1177/2473011420S00301
_version_ 1818214305873526784
author Jesse King BSc
Ben Murie
Julie C. Fanburg-Smith
Chris M. Stauch
Donald Flemming MD
Michael J. Klein
Elizabeth E. Frauenhoffer
Madelaine W. Fritsche BSc
Jessica Smith
John Elfar
Michael C. Aynardi MD
author_facet Jesse King BSc
Ben Murie
Julie C. Fanburg-Smith
Chris M. Stauch
Donald Flemming MD
Michael J. Klein
Elizabeth E. Frauenhoffer
Madelaine W. Fritsche BSc
Jessica Smith
John Elfar
Michael C. Aynardi MD
author_sort Jesse King BSc
collection DOAJ
description Category: Basic Sciences/Biologics; Ankle; Diabetes; Midfoot/Forefoot Introduction/Purpose: Charcot neuropathic arthropathy (CNA) is a debilitating, rapidly destructive degenerative joint disease that occurs in diabetic, neuropathic midfoot. Clinicoradiologic assessment for CNA previously relied on Eichenholtz Stage. There is limited data on CNA histopathology. The goal of this study was to independently develop a histopathologic scoring system for Charcot neuropathic arthropathy. Methods: Retrieval of surgical pathology specimens from neuroarthropathic CNA patients (2012-2019) were analyzed to evaluate joint soft tissue and bone. Considering progression from large to small periarticular bone fragments to resolution, we devised and applied a CNA FEMASK-score (named after coauthors): 0= intraneural arteriolosclerosis; 1= large bone fragments without host histiocytic response; 2= mixed bone fragments with host histiocytic response; 3= small minute bone spicules resorption to fibrosis. Clinical modified Eichenholtz staging and outcome were then compared the CNA FEMASK-score to assess for associations between these three elements. Results: Forty-eight cases of CNA included 34 males and 14 females, mean age 60.3 and age range 28-83 years, with clinical diabetes mellitus (predominantly Type II) and longstanding neuropathy. Elevated HbA1C, Eichenholtz stage, American Society of Anesthesia score, and Charlson comorbidity index were predictive of amputation. Pathologic specimens varied from fixation tissue to amputation. In addition to neurotraumatic, neurovascular and inflammatory findings, a distinctive intraneural hyalinized arteriolosclerosis was observed. FEMASK-scores:1 = 10%, 2= 58%, and 3=32%. FEMASK-score comparisons were 98% accurate compared with the modified Eichenholtz criteria scores of each patient and 98% reproducible among pathologists. FEMASK 2 and 3 correlates strongly with amputation. Conclusion: Our novel CNA FEMASK-score classification, derived from the largest cohort of diabetic neuropathic specimens, is reproducible, explains pathophysiology, correlates with Eichenholtz, and predicts amputation. The unique intraneural vasculopathy observed contributes to CNA etiology.
first_indexed 2024-12-12T06:18:05Z
format Article
id doaj.art-0f16499245dd4401a834ff98b86a251b
institution Directory Open Access Journal
issn 2473-0114
language English
last_indexed 2024-12-12T06:18:05Z
publishDate 2020-10-01
publisher SAGE Publishing
record_format Article
series Foot & Ankle Orthopaedics
spelling doaj.art-0f16499245dd4401a834ff98b86a251b2022-12-22T00:34:58ZengSAGE PublishingFoot & Ankle Orthopaedics2473-01142020-10-01510.1177/2473011420S00301Novel Pathology Classification System (FEMASK-Score) for Charcot Neuropathic Arthropathy Reveals Intraneural Vasculopathy and Predicts OutcomeJesse King BScBen MurieJulie C. Fanburg-SmithChris M. StauchDonald Flemming MDMichael J. KleinElizabeth E. FrauenhofferMadelaine W. Fritsche BScJessica SmithJohn ElfarMichael C. Aynardi MDCategory: Basic Sciences/Biologics; Ankle; Diabetes; Midfoot/Forefoot Introduction/Purpose: Charcot neuropathic arthropathy (CNA) is a debilitating, rapidly destructive degenerative joint disease that occurs in diabetic, neuropathic midfoot. Clinicoradiologic assessment for CNA previously relied on Eichenholtz Stage. There is limited data on CNA histopathology. The goal of this study was to independently develop a histopathologic scoring system for Charcot neuropathic arthropathy. Methods: Retrieval of surgical pathology specimens from neuroarthropathic CNA patients (2012-2019) were analyzed to evaluate joint soft tissue and bone. Considering progression from large to small periarticular bone fragments to resolution, we devised and applied a CNA FEMASK-score (named after coauthors): 0= intraneural arteriolosclerosis; 1= large bone fragments without host histiocytic response; 2= mixed bone fragments with host histiocytic response; 3= small minute bone spicules resorption to fibrosis. Clinical modified Eichenholtz staging and outcome were then compared the CNA FEMASK-score to assess for associations between these three elements. Results: Forty-eight cases of CNA included 34 males and 14 females, mean age 60.3 and age range 28-83 years, with clinical diabetes mellitus (predominantly Type II) and longstanding neuropathy. Elevated HbA1C, Eichenholtz stage, American Society of Anesthesia score, and Charlson comorbidity index were predictive of amputation. Pathologic specimens varied from fixation tissue to amputation. In addition to neurotraumatic, neurovascular and inflammatory findings, a distinctive intraneural hyalinized arteriolosclerosis was observed. FEMASK-scores:1 = 10%, 2= 58%, and 3=32%. FEMASK-score comparisons were 98% accurate compared with the modified Eichenholtz criteria scores of each patient and 98% reproducible among pathologists. FEMASK 2 and 3 correlates strongly with amputation. Conclusion: Our novel CNA FEMASK-score classification, derived from the largest cohort of diabetic neuropathic specimens, is reproducible, explains pathophysiology, correlates with Eichenholtz, and predicts amputation. The unique intraneural vasculopathy observed contributes to CNA etiology.https://doi.org/10.1177/2473011420S00301
spellingShingle Jesse King BSc
Ben Murie
Julie C. Fanburg-Smith
Chris M. Stauch
Donald Flemming MD
Michael J. Klein
Elizabeth E. Frauenhoffer
Madelaine W. Fritsche BSc
Jessica Smith
John Elfar
Michael C. Aynardi MD
Novel Pathology Classification System (FEMASK-Score) for Charcot Neuropathic Arthropathy Reveals Intraneural Vasculopathy and Predicts Outcome
Foot & Ankle Orthopaedics
title Novel Pathology Classification System (FEMASK-Score) for Charcot Neuropathic Arthropathy Reveals Intraneural Vasculopathy and Predicts Outcome
title_full Novel Pathology Classification System (FEMASK-Score) for Charcot Neuropathic Arthropathy Reveals Intraneural Vasculopathy and Predicts Outcome
title_fullStr Novel Pathology Classification System (FEMASK-Score) for Charcot Neuropathic Arthropathy Reveals Intraneural Vasculopathy and Predicts Outcome
title_full_unstemmed Novel Pathology Classification System (FEMASK-Score) for Charcot Neuropathic Arthropathy Reveals Intraneural Vasculopathy and Predicts Outcome
title_short Novel Pathology Classification System (FEMASK-Score) for Charcot Neuropathic Arthropathy Reveals Intraneural Vasculopathy and Predicts Outcome
title_sort novel pathology classification system femask score for charcot neuropathic arthropathy reveals intraneural vasculopathy and predicts outcome
url https://doi.org/10.1177/2473011420S00301
work_keys_str_mv AT jessekingbsc novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome
AT benmurie novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome
AT juliecfanburgsmith novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome
AT chrismstauch novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome
AT donaldflemmingmd novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome
AT michaeljklein novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome
AT elizabethefrauenhoffer novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome
AT madelainewfritschebsc novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome
AT jessicasmith novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome
AT johnelfar novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome
AT michaelcaynardimd novelpathologyclassificationsystemfemaskscoreforcharcotneuropathicarthropathyrevealsintraneuralvasculopathyandpredictsoutcome